PMA supplement
P840040 S044: SYNERGY(TM) CONVERTIBLE RAPID EXCHANGE PTCA CATH
FDA PMA supplement · Special (Immediate Track) · Boston Scientific Corp
Key facts
| Original PMA | P840040 |
|---|---|
| Supplement number | S044 |
| Supplement type | Special (Immediate Track) |
| Reason for the supplement | Location Change - Manufacturer/Sterilizer/Packager/Supplier |
| Trade name | SYNERGY(TM) CONVERTIBLE RAPID EXCHANGE PTCA CATH |
| Generic name | Catheters, transluminal coronary angioplasty, percutaneous |
| Applicant | Boston Scientific Corp |
| Product code | LOX |
| Received date | Jul 5, 1994 |
| Decision date | Jul 26, 1994 |
At a glance
- No Expedited review granted
- No Approval order on file
- No Summary of safety and effectiveness on file
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMA supplements
A PMA supplement asks FDA to approve a change to a device that already holds a premarket approval: a new indication, a design or labeling change, a manufacturing site or process change.
Source: U.S. Food and Drug Administration (FDA), Premarket Approval (PMA) database · Source date: